VIVO - Meridian Bioscience EPS beats by $0.33 beats on revenue August, 07 2020 07:32 AM Meridian Bioscience Inc. Meridian Bioscience (NASDAQ:VIVO): Q3 Non-GAAP EPS of $0.56 beats by $0.33; GAAP EPS of $0.64 beats by $0.45.More news on: Meridian Bioscience, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...